Down 62%. Should You Buy TransMedics Stock on the Dip?
It's been a rough several months for TransMedics Group (NASDAQ: TMDX) shareholders. The stock has been beaten down by about ...
TRANSMEDICS (TMDX) INVESTOR ALERT: Berger Montague Advises Investors to Inquire About a Securities Fraud Class Action
According to the lawsuit, throughout the Class Period, the Company and its senior executives misled investors and/or failed to disclose that: (1) TransMedics used kickbacks, fraudulent overbilling, ...
TMDX SHAREHOLDER NOTICE: TransMedics Group, Inc. Investors are Reminded to Contact BFA Law before the April 15 Class Action Deadline
New York, New York-- (Newsfile Corp. - March 13, 2025) - Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against TransMedics Group, Inc. (NASDAQ: TMDX) ...
Zacks.com on MSN13d
TransMedics Stock Rises as Q4 Earnings & Revenues Beat Estimates
TMDX's fourth-quarter earnings depict strength in the company's net product revenues and services revenues. A rise in ...
TransMedics' Revenue Surged 49.8% in Q4
The organ transplant technology specialist significantly exceeded Wall Street's estimates in the fourth quarter.
Seeking Alpha10d
TransMedics: Aggressive Guidance Largely Ignored By The Market
TransMedics' stock has rebounded modestly in recent months on the back of a strong fourth quarter performance. Continued market growth and TransMedics' return to gaining market share should help ...
The Motley Fool3d
Down 62%. Should You Buy TransMedics Stock on the Dip?
TransMedics Group's organ care system can preserve multiple organs, but livers are responsible for 70% of total sales. OrganOx markets a normothermic machine perfusion device approved to preserve ...
Yahoo Finance7d
A Closer Look At TransMedics Group's Earnings
Over the twelve months to December 2024, TransMedics Group recorded an accrual ratio of 0.36. Unfortunately, that means its free cash flow was a lot less than its statutory profit, which makes us ...
Morningstar4d
TransMedics Group (TMDX) Faces Class-Action Suit Over Alleged Fraud and Safety Lapses– Hagens Berman
SAN FRANCISCO, March 10, 2025 (GLOBE NEWSWIRE) -- A class-action lawsuit has been filed against TransMedics Group, Inc. (NASDAQ: TMDX), a medical technology company specializing in organ ...
Nasdaq3d
Down 62%. Should You Buy TransMedics Stock on the Dip?
It's been a rough several months for TransMedics Group (NASDAQ: TMDX) shareholders. The stock has been beaten down by about 62% from the peak it set last August. The company's warm perfusion ...
William Blair Lifts Earnings Estimates for TransMedics Group
Equities research analysts at William Blair raised their Q3 2025 earnings estimates for shares of TransMedics Group in a ...
Morningstar7d
TransMedics Group (TMDX) Plunges Amidst Allegations of Fraud, Organ Trafficking – Hagens Berman
SAN FRANCISCO, March 07, 2025 (GLOBE NEWSWIRE) -- A class-action lawsuit has been filed against TransMedics Group, Inc. (NASDAQ: TMDX), a medical technology company specializing in organ ...